comparemela.com

Latest Breaking News On - James vane tempest - Page 2 : comparemela.com

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Jefferies remains a Sell rating

Jefferies s analyst James Vane-Tempest maintains his Sell rating on the stock. The target price continues to be set at EUR 32.

James-vane-tempest
Markets

FRESENIUS SE : Jefferies remains its Buy rating

James Vane-Tempest from Jefferies retains his positive opinion on the stock with a Buy rating. The target price is unchanged at EUR 40.

James-vane-tempest
Markets

FRESENIUS SE : Jefferies reiterates its Buy rating

In his latest research note, analyst James Vane-Tempest confirms his positive recommendation. The broker Jefferies is keeping its Buy rating. The target price is set at 40 versus 41 EUR.

James-vane-tempest

GERRESHEIMER AG : Jefferies remains its Buy rating

In his latest research note, analyst James Vane-Tempest confirms his positive recommendation. The broker Jefferies is keeping its Buy rating. No major update to the target price set at EUR 126.

James-vane-tempest
Markets

FRESENIUS SE : Receives a Buy rating from Jefferies

In his latest research note, analyst James Vane-Tempest confirms his positive recommendation. The broker Jefferies is keeping its Buy rating. The target price is still set at EUR 41.

James-vane-tempest
Markets

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.